CINECA IRIS Institutional Research Information System

DA SETTIMO PASSETTI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.745
AS - Asia 11.710
EU - Europa 11.269
SA - Sud America 1.581
AF - Africa 543
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 3
Totale 49.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.948
IT - Italia 4.413
SG - Singapore 3.622
CN - Cina 3.556
SE - Svezia 1.934
HK - Hong Kong 1.907
BR - Brasile 1.341
DE - Germania 1.249
BG - Bulgaria 843
TR - Turchia 700
CA - Canada 646
VN - Vietnam 597
GB - Regno Unito 575
RU - Federazione Russa 441
FI - Finlandia 397
AT - Austria 347
UA - Ucraina 340
IN - India 302
KR - Corea 265
FR - Francia 221
JP - Giappone 189
CI - Costa d'Avorio 161
CH - Svizzera 108
NG - Nigeria 101
BD - Bangladesh 87
MX - Messico 79
AR - Argentina 75
IQ - Iraq 73
BE - Belgio 72
AU - Australia 71
NL - Olanda 68
PL - Polonia 67
PK - Pakistan 66
SN - Senegal 66
ZA - Sudafrica 65
SA - Arabia Saudita 49
ID - Indonesia 47
ES - Italia 44
UZ - Uzbekistan 41
EC - Ecuador 35
CO - Colombia 34
EG - Egitto 34
VE - Venezuela 31
KE - Kenya 29
CZ - Repubblica Ceca 25
JO - Giordania 23
MA - Marocco 23
MY - Malesia 21
AZ - Azerbaigian 20
IE - Irlanda 19
GR - Grecia 18
JM - Giamaica 18
LT - Lituania 17
AE - Emirati Arabi Uniti 16
PY - Paraguay 16
DZ - Algeria 15
PE - Perù 15
TW - Taiwan 14
IR - Iran 13
KZ - Kazakistan 13
UY - Uruguay 13
CL - Cile 12
OM - Oman 12
BJ - Benin 10
DK - Danimarca 10
TT - Trinidad e Tobago 10
IL - Israele 9
LB - Libano 9
AL - Albania 8
PT - Portogallo 8
GE - Georgia 7
PA - Panama 7
PH - Filippine 7
PS - Palestinian Territory 7
RO - Romania 7
BO - Bolivia 6
CR - Costa Rica 6
ET - Etiopia 6
BF - Burkina Faso 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
EE - Estonia 5
HU - Ungheria 5
NI - Nicaragua 5
TN - Tunisia 5
BN - Brunei Darussalam 4
HN - Honduras 4
PR - Porto Rico 4
QA - Qatar 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CY - Cipro 3
GA - Gabon 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LY - Libia 3
MN - Mongolia 3
RS - Serbia 3
Totale 49.860
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.893
Ashburn 2.340
Ann Arbor 2.320
Houston 2.072
Singapore 1.897
Hong Kong 1.884
Serra 1.616
Chandler 1.591
Fairfield 1.559
Santa Clara 1.294
Dallas 1.117
Sofia 842
Milan 767
Beijing 750
Shanghai 742
Seattle 628
Wilmington 624
New York 580
Ottawa 541
Izmir 498
Cambridge 475
Jacksonville 416
Boardman 412
Los Angeles 392
Princeton 384
Hefei 349
Lawrence 334
Nanjing 296
Vienna 287
Medford 276
Seoul 253
Des Moines 215
Dong Ket 209
London 209
Frankfurt am Main 201
Rho 180
Abidjan 161
Istanbul 156
Dearborn 155
Pisa 134
Buffalo 133
Redondo Beach 131
Rome 114
Tokyo 111
São Paulo 109
Council Bluffs 108
Munich 106
Lagos 99
Nanchang 96
Bern 94
Bremen 94
Florence 93
Chicago 87
San Diego 86
Ho Chi Minh City 84
Düsseldorf 83
The Dalles 81
San Jose 78
Redwood City 76
Brussels 71
Columbus 71
Ogden 70
Boulder 69
Jüchen 68
Shenyang 67
Dakar 66
Kunming 65
Pune 65
Hebei 59
Turku 53
Falls Church 52
Warsaw 52
Changsha 49
Fuzhou 47
San Francisco 47
Helsinki 46
Nürnberg 46
Guangzhou 45
Hanoi 45
Sydney 44
Lucca 43
Belo Horizonte 42
Tashkent 39
Tianjin 39
Johannesburg 38
Auburn Hills 36
Rio de Janeiro 36
Toronto 36
Norwalk 35
Washington 34
Livorno 32
Nuremberg 31
Paris 31
Quanzhou 30
Hangzhou 29
Jiaxing 29
Brasília 28
Marseille 28
Phoenix 27
Dhaka 26
Totale 35.778
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 383
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 335
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 320
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 272
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 266
Soyasaponins from Zolfino bean as aldose reductase differential inhibitors 264
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 260
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 257
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 248
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 233
N '-phenylindol-3-ylglyoxylohydrazide derivatives: Synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors 230
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 226
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 223
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 223
Allosteric modulators of human A2B adenosine receptor. 222
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 219
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 218
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 216
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 216
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 214
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 214
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 211
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 211
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 210
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 209
Functional Studies in the Year of Pulses: the case of Zolfino landraces (Phaesolus vulgaris L.) 207
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 206
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 205
The ra structure of tellurophene-2-carboxaldehyde by using the proton NMR spectrum in an oriented phase including carbon-13 and tellurium-125 satellites 201
An update into the medicinal chemistry of translocator protein (TSPO) ligands 201
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 200
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 199
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 198
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 198
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 198
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 197
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 196
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 194
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 193
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 191
1-Substituted 2-(benzylamino)benzimidazole derivatives: compounds with H1-antihistaminic activity 190
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 190
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 189
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 189
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 188
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 187
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 186
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 186
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 186
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 185
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 184
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 183
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 183
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 183
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 183
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 183
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 182
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 182
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 181
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 181
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 179
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 179
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 178
Pursuing Aldose Reductase Inhibitors through in Situ Cross-Docking and Similarity-Based Virtual Screening 178
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 178
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 177
Synthesis of novel 1-aryl[1]benzoxepino[5,4-c]pyrazole and [1]benzoxepino[5,4-d]pyrimidine derivatives 176
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 175
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 174
Metformin conjugates and therapeutic use thereof 173
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 173
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 173
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 173
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 173
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 172
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 172
SPECIFIC-INHIBITION OF BENZODIAZEPINE RECEPTOR-BINDING BY SOME N-(INDOL-3-YLGLYOXYLYL)AMINO ACID-DERIVATIVES - STEREOSELECTIVE INTERACTIONS 172
Novel, Highly Potent Aldose Reductase Inhibitors:Cyano(2-oxo-2,3-dihydroindol-3-yl)acetic Acid Derivatives 172
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 172
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 172
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 170
FACILE SYNTHESIS OF 3-SUBSTITUTED[1,2,4]TRIAZINO[3,4-F]PURINE-4,6,8-TRIONE DERIVATIVES 170
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 169
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 169
An approach to novel fused triazole or tetrazole derivatives starting from Benzimidazo[1,2-a]quinazoline-5(7H)-one and 5,7-Dihydro-5-oxopyrido[3',2':5,6]pyrimido[1,2-a]benzimidazole 168
Synthesis of novel pyrido[3',2':5,6]thiopyrano[3,2-b]indol-5(6H)-ones and 6H-pyrido[3',2':5,6]thiopyrano[4,3-b]quinolines,two new heterocyclic systems. 168
A New Approach to Control the Enigmatic Activity of Aldose Reductase 168
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 168
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 168
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 168
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 166
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 166
A search for quantum mechanical methods suitable for the conformational analysis of models related to some inverse agonists of the benzodiazepine receptor 165
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 164
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors 164
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 164
Synthesis of novel 1,4-dihydropyrido[3’,2’:5,6]thiopyrano[4,3-c]-pyrazoles and 5H-pyrido[3’,2’:5,6]thiopyrano[4,3-d]pyrimidines as potential antiproliferative agents 163
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 163
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 162
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 161
Totale 19.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.608 0 0 0 0 0 112 97 263 272 231 156 477
2021/20224.047 100 333 155 250 673 552 120 203 144 131 234 1.152
2022/20235.403 675 817 372 540 602 693 60 397 907 30 245 65
2023/20243.696 424 364 419 224 495 722 190 108 64 92 186 408
2024/202511.087 73 407 114 690 1.195 1.074 827 544 1.034 1.424 1.170 2.535
2025/20266.903 661 1.543 1.420 943 1.228 1.108 0 0 0 0 0 0
Totale 50.691